ArticleTheranostics2022

CLP36 promotes p53 deficient sarcoma progression through suppression of atrophin-1 interacting protein-4 (AIP-4)-dependent degradation of YAP1.

Yixuan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.